NCAM1 and B-cell chronic lymphocytic leukemia: We observed a complete lack of signal detection for CD56 and CD209 on serum-derived EVs from CLL samples, while there was a clear signal on serum-derived EVs from AML, ALL, and Healthy samples (Fig. 4).